Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition (Q44146198)

30 November 2017

title

Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition (English)

1 reference

30 November 2017

0 references

D-H Kim

1

1 reference

30 November 2017

J-C Lee

2

1 reference

30 November 2017

M-K Lee

3

1 reference

30 November 2017

K-W Kim

4

1 reference

30 November 2017

M-S Lee

5

1 reference

30 November 2017

language of work or name

1 reference

27 September 2012

1 reference

30 November 2017

1 reference

30 November 2017

volume

55

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

3308-3317

1 reference

Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Inhibition of Autoimmune Diabetes by TLR2 Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Extra-insular beta cells associated with ductules are frequent in adult human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

CD3-specific antibodies: a portal to the treatment of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Dendritic cell-expanded, islet-specific CD4 CD25 CD62L regulatory T cells restore normoglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Modulators of arginine metabolism support cancer immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

TLR2 signaling improves immunoregulation to prevent type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Evaluation of a Lipopeptide Immunogen as a Therapeutic in HIV Type 1-Seropositive Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-012-2723-X

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells

21 January 2018

1 reference

12 December 2020

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

12 December 2020

Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses

1 reference

12 December 2020

Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis

1 reference

12 December 2020

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice

1 reference

12 December 2020

Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes

1 reference

12 December 2020

Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes

1 reference

12 December 2020

10.1007/S00125-012-2723-X

Identifiers

DOI

1 reference

30 November 2017

1 reference